---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-23-000024"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T09:55:28.137808+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health enters $10M equity purchase agreement with Lincoln Park Capital

## Summary
- Company can sell up to $10M of common stock to Lincoln Park over 36 months at its discretion.
- Pricing based on market price with discount; regular purchases up to 100k-300k shares per day depending on stock price.
- Commitment fee of 715,990 shares issued to Lincoln Park; no cash proceeds from those shares.
- Proceeds to be used for product pipeline development, working capital, and general corporate purposes.
- Lincoln Park prohibited from short selling or hedging; company can terminate agreement at any time without penalty.

## SEC filing metadata
- accession: 0000926617-23-000024
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661723000024/0000926617-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661723000024/awh-20230328x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-23-000024
- JSON: https://secwatch.observer/filing/0000926617-23-000024.json
- Plain text: https://secwatch.observer/filing/0000926617-23-000024.txt

## Key facts
- Material Agreements
  Aspira Women's Health Inc. entered into Purchase Agreement with Lincoln Park Capital Fund, LLC valued at up to $10,000,000 (effective 2023-03-28).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Lincoln Park Capital Fund, LLC
  - Value: up to $10,000,000
  - Effective: 2023-03-28
  source text: On March 28 , 202 3, Aspira Women’s Health Inc. (the “Company”) and Lincoln Park Capital Fund, LLC (“Lincoln Park”) entered into a purchase agreement (the “Purchase Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000024/0000926617-23-000024-index.htm
- Material Agreements
  Aspira Women's Health Inc. entered into Registration Rights Agreement with Lincoln Park Capital Fund, LLC (effective 2023-03-28).
  - Action: entry
  - Counterparty: Lincoln Park Capital Fund, LLC
  - Effective: 2023-03-28
  source text: (the “Company”) and Lincoln Park Capital Fund, LLC (“Lincoln Park”) entered into a purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”), pursuant to which the Company has the right, in its sole discretion, to sell to Lincoln Park shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate value of up to $10,000,000 (the “Purchase Shares”), subject to certain limitations and conditions set forth in the Purchase Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000024/0000926617-23-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.